Literature DB >> 9270

Antihistamines: pharmacology and clinical use.

D S Pearlman.   

Abstract

Antihistamines are a diverse group of drugs which possess the ability to inhibit various histaminic actions. By and large, they bear a certain structural resemblance to histamine, and act principally to prevent histamine-receptor interaction through competition with histamine for histamine receptors. Consequently, they are helpful therapeutically in preventing, rather than reversing, histaminic actions. Individual antihistaminic drugs act to inhibit histaminic action at one or another histamine receptor (H1 or H2-receptor), but not at both receptors. The large number of antihistaminics which have been available for many years and employed chiefly as 'antiallergic' drugs are classified as H1-receptor inhibitors; they are most effective therapeutically in inhibiting manifestations of histamine-induced wheal and erythema formation and pruritus. H2-receptor inhibitors, agents which are able to inhibit histamine-induced gastric acid secretion, have been developed more recently. Antihistaminics in general and H1-receptor inhibitors in particular, exert a wide variety of pharmacological activities. Their use is frequently accompanied by undesirable side-effects, notably CNS depression, dryness of mucous membranes, and gastrointestinal effects. Used judiciously and in proper dosage, antihistaminic drugs are helpful in the control of allergic disorders, allergic rhinitis and urticaria in particular; newly developed H2-receptor inhibitors show therapeutic promise in the treatment of peptic ulceration.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 9270     DOI: 10.2165/00003495-197612040-00002

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  78 in total

Review 1.  EVALUATION OF THE TERATOGENICITY OF DRUGS.

Authors:  R L CAHEN
Journal:  Clin Pharmacol Ther       Date:  1964 Jul-Aug       Impact factor: 6.875

2.  Ultraviolet light factor in chlorpromazine dermatitis.

Authors:  M M CAHN; E J LEVY
Journal:  AMA Arch Derm       Date:  1957-01

3.  Histamine release by antihistamines.

Authors:  O ARUNLAKSHANA
Journal:  J Physiol       Date:  1953-03       Impact factor: 5.182

4.  The development of tolerance to antihistamines; a study of the quantitative inhibiting capacity of antihistamines on the skin and mucous membrane reaction to histamine and antigens.

Authors:  T B DANNENBERG; S M FEINBERG
Journal:  J Allergy       Date:  1951-07

5.  Sensitization to antistine.

Authors:  M M MOSKO; W L PETERSON
Journal:  J Invest Dermatol       Date:  1950-01       Impact factor: 8.551

6.  The pharmacology of cimetidine, a new histamine H2-receptor antagonist.

Authors:  R W Brimblecombe; W A Duncan; G J Durant; C R Ganellin; M E Parsons; J W Black
Journal:  Br J Pharmacol       Date:  1975-03       Impact factor: 8.739

7.  Degree and duration of skin test suppression and side effects with antihistamines. A double blind controlled study with five antihistamines.

Authors:  T J Cook; D M MacQueen; H J Wittig; J I Thornby; R L Lantos; C M Virtue
Journal:  J Allergy Clin Immunol       Date:  1973-02       Impact factor: 10.793

8.  Inhibition of histamine release by histamine controlled by H2 receptor.

Authors:  L M Lichtenstein; E Gillespie
Journal:  Nature       Date:  1973-08-03       Impact factor: 49.962

9.  Activation of histidine decarboxylase by H2-receptor blockade: mechanism of action.

Authors:  R Häkanson; J Hedenbro; G Liedberg; J F Rehfeld; F Stadil
Journal:  Br J Pharmacol       Date:  1975-01       Impact factor: 8.739

10.  The anti-histamine properties of benadryl, beta-di-methylaminoethyl benzhydryl ether hydrochloride.

Authors:  E R LOEW; R MacMILLAN; M E KAISER
Journal:  J Pharmacol Exp Ther       Date:  1946-03       Impact factor: 4.030

View more
  8 in total

1.  Analysis of spatiotemporal pattern and quantification of gastrointestinal slow waves caused by anticholinergic drugs.

Authors:  Kelvin K L Wong; Lauren C Y Tang; Jerry Zhou; Vincent Ho
Journal:  Organogenesis       Date:  2017-02-23       Impact factor: 2.500

2.  Oxatomide, a new orally active drug which inhibits both the release and the effects of allergic mediators.

Authors:  F Awouters; C J Niemegeers; J Van den Berk; J M Van Neuten; F M Lenaerts; M Borgers; K H Schellekens; A Broeckaert; J De Cree; P A Janssen
Journal:  Experientia       Date:  1977-12-15

Review 3.  Chronic rhinitis in children.

Authors:  D S Pearlman
Journal:  Clin Rev Allergy       Date:  1984-08

4.  Nasal decongestants.

Authors:  D W Empey; K T Medder
Journal:  Drugs       Date:  1981-06       Impact factor: 9.546

Review 5.  Chronic urticaria: aetiology, management and current and future treatment options.

Authors:  Martina M A Kozel; Ruth A Sabroe
Journal:  Drugs       Date:  2004       Impact factor: 9.546

6.  Pharmacologic analysis of LY188695 (KB-2413), 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)-benzimidazole difumarate, a potent histamine1 receptor antagonist.

Authors:  J H Fleisch; L E Rinkema; K D Haisch; C A Whitesitt
Journal:  Agents Actions       Date:  1987-02

Review 7.  Drug treatment of allergic conjunctivitis. A review of the evidence.

Authors:  G Ciprandi; S Buscaglia; P M Cerqueti; G W Canonica
Journal:  Drugs       Date:  1992-02       Impact factor: 9.546

Review 8.  Antihistamines for the common cold.

Authors:  An I M De Sutter; Avadhesh Saraswat; Mieke L van Driel
Journal:  Cochrane Database Syst Rev       Date:  2015-11-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.